Ahmedabad-based pharma company ‘Corona Remedies’ entered the stock market on Monday. The entry was also good. The IPO of Corona Remedies also received a tremendous response from investors. The subscription of its IPO was 144 times more. Now when it was listed on Monday, it gave a profit of 38% to the investors as soon as it opened.

The IPO of Corona Remedies was open for subscription between 8 and 10 December. It was subscribed 144 times more. Its share price was kept at Rs 1,062 per share. When the market opened on Monday and its listing took place, its price went up by 38%.

Read this also– Top 10% rich capture 65% of wealth; How much inequality is there in India?

How much did the share price reach?

The stock of Corona Remedies was listed on both the stock exchanges – Bombay Stock Exchange (BSE) and National Stock Exchange (NSE).

The price of one share of Corona Remedies rose by 36.72% to Rs 1,452 on BSE. After some time it increased by 41.14% to Rs 1,499. At the same time, its price on NSE rose by 38.41% to Rs 1,470.

This means that its investors got a return of more than 38% on the very first day. The employees of the company must have made even more profit, because they got one share at Rs 1,008.

The company also benefited tremendously as the share price rose as soon as the market opened. With this the company’s market reached Rs 8,996.65 crore.

Read this also–India’s rice quenches the world’s hunger, but why is Trump angry with it?

What are Corona Remedies?

This is a company based in Ahmedabad, Gujarat, which was formed in 2004. This company manufactures women’s health products, heart and diabetes medicines, pain killers, urology and medicines to chronic diseases. The company’s revenue in 2024-25 was more than Rs 1,200 crore. Its profit was Rs 149 crore.